Showcases blood glucose and glycated hemoglobin analyzers

GC Noksipja Emeseu announced on the 19th that it participated in WHX Labs Dubai 2026, the world's largest healthcare exhibition, held in Dubai, United Arab Emirates (UAE) from the 10th to the 13th (local time).


WHX Labs Dubai is a global healthcare exhibition representing the Middle East region, and this year, marking its 25th anniversary, it was held on the largest scale ever. The exhibition brought together more than 850 global healthcare companies from around 180 countries and over 40,000 industry professionals.

GC Noksipja Emeseu, a company specializing in in vitro diagnostics, participated in WHX Labs Dubai 2026, the world's largest healthcare exhibition, held in Dubai, United Arab Emirates (UAE) from the 10th to the 13th (local time). GC Noksipja Emeseu

GC Noksipja Emeseu, a company specializing in in vitro diagnostics, participated in WHX Labs Dubai 2026, the world's largest healthcare exhibition, held in Dubai, United Arab Emirates (UAE) from the 10th to the 13th (local time). GC Noksipja Emeseu

View original image

GC Noksipja Emeseu has operated its own independent booth every year since it first participated in 2014. This year, the company focused on showcasing its point-of-care testing (POCT) product lineup, including blood glucose meters, glycated hemoglobin (HbA1c) analyzers, and hemoglobin analyzers.



A GC Noksipja Emeseu representative said, "Through this exhibition, we are accelerating the expansion of our overseas markets, particularly in emerging countries in the Middle East, Europe, and Africa," adding, "We will further solidify our position as a leading company in the in vitro diagnostics field through continuous technology development and stronger global marketing."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing